Effects of Intravenous Atrial Natriuretic Peptide on Cardiac Sympathetic Nerve Activity and Left Ventricular Remodeling in Patients With First Anterior Acute Myocardial Infarction

Journal of the American College of Cardiology

Volumn 49, Issue 6, 2007, Pages 667-674

  Kasama, Shu ^a   Toyama, Takuji ^a   Hatori, Takashi ^a   Sumino, Hiroyuki ^a   Kumakura, Hisao ^b   Takayama, Yoshiaki ^b   Ichikawa, Shuichi ^b   Suzuki, Tadashi ^a   Kurabayashi, Masahiko ^a  

^a GUNMA UNIVERSITY   (Japan)

^b Cardiovasc Hosp of Central Japan   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE; ATRIAL NATRIURETIC FACTOR; CREATINE KINASE; IODINE 123; ISOSORBIDE DINITRATE; PYROPHOSPHATE TECHNETIUM TC 99M;

ACUTE HEART INFARCTION; ADULT; AGE; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; FEMALE; GENDER; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART MUSCLE INJURY; HEART NERVE; HEART VENTRICLE REMODELING; HEART VENTRICULOGRAPHY; HUMAN; MALE; MEDIASTINUM; NERVE CONDUCTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECANALIZATION; SCINTIGRAPHY; SCORING SYSTEM; SYMPATHETIC NERVE; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ATRIAL NATRIURETIC FACTOR; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; ISOSORBIDE DINITRATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; SYMPATHETIC NERVOUS SYSTEM; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR REMODELING;

EID: 33846811341     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.09.048     Document Type: Article

References (45)

1. Mahmarian J.J., Mahmarian A.C., Marks G.F., Pratt C.M., and Verani M.S. Role of adenosine thallium-201 tomography for defining long-term risk in patients after acute myocardial infarction. J Am Coll Cardiol 25 (1995) 1333-1340
2. Sanz G., Castaner A., Betriu A., et al. Determinants of prognosis in survivors of myocardial infarction: a prospective clinical angiographic study. N Engl J Med 306 (1982) 1065-1070
3. White H.D., Norris R.M., Brown M.A., Brandt P.W., Whitlock R.M., and Wild C.J. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 76 (1987) 44-51
4. Thomas J.A., and Marks B.H. Plasma norepinephrine in congestive heart failure. Am J Cardiol 41 (1978) 233-243
5. Karlsberg R.P., Cryer P.E., and Roberts R. Serial plasma catecholamine response early in the course of clinical acute myocardial infarction: relationship to infarct extent and mortality. Am Heart J 102 (1981) 24-29
6. Jugdutt B.I., and Warnica J.W. Intravenous nitroglycerin therapy to limit myocardial infarct size, expansion, and complications. Effect of timing, dosage, and infarct location. Circulation 78 (1988) 906-919
7. Kosuge M., Miyajima E., Kimura K., Ishikawa T., Tochikubo O., and Ishii M. Comparison of atrial natriuretic peptide versus nitroglycerin for reducing blood pressure in acute myocardial infarction. Am J Cardiol 81 (1998) 781-784
8. Levin E.R., Gardner D.G., and Samson W.K. Natriuretic peptides. N Engl J Med 339 (1998) 321-328
9. Hayashi M., Tsutamoto T., Wada A., et al. Intravenous atrial natriuretic peptide prevents left ventricular remodeling in patients with first anterior acute myocardial infarction. J Am Coll Cardiol 37 (2001) 1820-1826
10. Sakata K., Mochizuki M., Yoshida H., et al. Cardiac sympathetic dysfunction contributes to left ventricular remodeling after acute myocardial infarction. Eur J Nucl Med 27 (2000) 1641-1649
11. Matsunari I., Schricke U., Bengel F.M., et al. Extent of cardiac sympathetic neuronal damage is determined by the area of ischemia in patients with acute coronary syndromes. Circulation 101 (2000) 2579-2585
12. Takeishi Y., Atsumi H., Fujiwara S., Takahashi K., and Tomoike H. ACE inhibition reduces cardiac iodine-123-MIBG release in heart failure. J Nucl Med 38 (1997) 1085-1089
13. Toyama T., Aihara Y., Iwasaki T., et al. Cardiac sympathetic activity estimated by 123I-MIBG myocardial imaging in patients with dilated cardiomyopathy after beta-blocker or angiotensin-converting enzyme inhibitor therapy. J Nucl Med 40 (1999) 217-223
14. Kasama S., Toyama T., Kumakura H., et al. Spironolactone improves cardiac sympathetic nerve activity and symptoms in patients with congestive heart failure. J Nucl Med 43 (2002) 1279-1285
15. Kasama S., Toyama T., Kumakura H., et al. Effect of spironolactone on cardiac sympathetic nerve activity and left ventricular remodeling in patients with dilated cardiomyopathy. J Am Coll Cardiol 41 (2003) 574-581
16. Kasama S., Toyama T., Kumakura H., et al. Addition of valsartan to an angiotensin-converting enzyme inhibitor improves cardiac sympathetic nerve activity and left ventricular function in patients with congestive heart failure. J Nucl Med 44 (2003) 884-890
17. Kasama S., Toyama T., Kumakura H., et al. Effects of intravenous atrial natriuretic peptide on cardiac sympathetic nerve activity in patients with decompensated congestive heart failure. J Nucl Med 45 (2004) 1108-1113
18. Kasama S., Toyama T., Kumakura H., et al. Effects of candesartan on cardiac sympathetic nerve activity in patients with congestive heart failure and preserved left ventricular ejection fraction. J Am Coll Cardiol 45 (2005) 661-667
19. Kasama S., Toyama T., Kumakura H., et al. Effects of perindopril on cardiac sympathetic nerve activity in patients with congestive heart failure: comparison with enalapril. Eur J Nucl Med Mol Imaging 32 (2005) 964-971
20. Kasama S., Toyama T., Hatori T., et al. Comparative effects of valsartan with enalapril on cardiac sympathetic nerve activity and plasma brain natriuretic peptide in patients with congestive heart failure. Heart 92 (2006) 625-630
21. Chesebro J.H., Knatterud G., Roberts R., et al. Thrombolysis In Myocardial Infarction (TIMI) trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation 76 (1987) 142-154
22. Cerqueira M.D., Weissman N.J., Dilsizian V., et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105 (2002) 539-542
23. Kasama S., Toyama T., Kumakura H., et al. Effects of nicorandil on cardiac sympathetic nerve activity after reperfusion therapy in patients with first anterior acute myocardial infarction. Eur J Nucl Med Mol Imaging 32 (2005) 322-328
24. Grines C.L., Browne K.F., Marco J., et al., Primary Angioplasty in Myocardial Infarction Study Group. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 328 (1993) 673-679
25. Lamas G.A., Flaker G.C., Mitchell G., et al., Survival and Ventricular Enlargement Investigators. Effect of infarct artery patency on prognosis after acute myocardial infarction. Circulation 92 (1995) 1101-1109
26. Kloner R.A. Does reperfusion injury exist in humans?. J Am Coll Cardiol 21 (1993) 537-545
27. Emori T., Hirata Y., Imai T., Eguchi S., Kanno K., and Marumo F. Cellular mechanism of natriuretic peptides-induced inhibition of endothelin-1 biosynthesis in rat endothelial cells. Endocrinology 133 (1993) 2474-2480
28. Murry C.E., Jennings R.B., and Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74 (1986) 1124-1136
29. Gross G.J., and Auchampach J.A. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res 70 (1992) 223-233
30. Okawa H., Horimoto H., Mieno S., Nomura Y., Yoshida M., and Shinjiro S. Preischemic infusion of alpha-human atrial natriuretic peptide elicits myoprotective effects against ischemia reperfusion in isolated rat hearts. Mol Cell Biochem 248 (2003) 171-177
31. Das B., Sarkar C., and Karanth K.S. Selective mitochondrial K(ATP) channel activation results in antiarrhythmic effect during experimental myocardial ischemia/reperfusion in anesthetized rabbits. Eur J Pharmacol 437 (2002) 165-171
32. Stokely E.M., Buja L.M., Lewis S.E., et al. Measurement of acute myocardial infarcts in dogs with 99mTc-stannous pyrophosphate scintigrams. J Nucl Med 17 (1976) 1-5
33. Holman B.L., Chisholm R.J., and Braunwald E. The prognostic implications of acute myocardial infarct scintigraphy with 99mTc-pyrophosphate. Circulation 57 (1978) 320-326
34. Koyanagi S., Eastham C.L., Harrison D.G., and Marcus M.L. Transmural variation in the relationship between myocardial infarct size and risk area. Am J Physiol 242 (1982) H867-H874
35. Schofer J., Mathey D.G., Montz R., Bleifeld W., and Stritzke P. Use of dual intracoronary scintigraphy with thallium-201 and technetium-99m pyrophosphate to predict improvement in left ventricular wall motion immediately after intracoronary thrombolysis in acute myocardial infarction. J Am Coll Cardiol 2 (1983) 737-744
36. Wieland D.M., Wu J., Brown L.E., Mangner T.J., Swanson D.P., and Beierwaltes W.H. Radiolabeled adrenergic neuron-blocking agents: adrenomedullary imaging with [131I]iodobenzylguanidine. J Nucl Med 21 (1980) 349-353
37. Schofer J., Spielmann R., Schuchert A., Weber K., and Schluter M. Iodine-123 meta-iodobenzylguanidine scintigraphy: a noninvasive method to demonstrate myocardial adrenergic nervous system disintegrity in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 12 (1988) 1252-1258
38. Miura T., Kawamura S., Tatsuno H., et al. Ischemic preconditioning attenuates cardiac sympathetic nerve injury via ATP-sensitive potassium channels during myocardial ischemia. Circulation 104 (2001) 1053-1058
39. Buss S.J., Backs J., Kreusser M.M., et al. Spironolactone preserves cardiac norepinephrine reuptake in salt-sensitive Dahl rats. Endocrinology 147 (2006) 2526-2534
40. Ito T., Yoshimura M., Nakamura S., et al. Inhibitory effect of natriuretic peptides on aldosterone synthase gene expression in cultured neonatal rat cardiocytes. Circulation 107 (2003) 807-810
41. Hayashi M., Tsutamoto T., Wada A., et al. Relationship between transcardiac extraction of aldosterone and left ventricular remodeling in patients with first acute myocardial infarction: extracting aldosterone through the heart promotes ventricular remodeling after acute myocardial infarction. J Am Coll Cardiol 38 (2001) 1375-1382
42. Suzuki S., Yoshimura M., Nakayama M., et al. Plasma level of B-type natriuretic peptide as a prognostic marker after acute myocardial infarction: a long-term follow-up analysis. Circulation 110 (2004) 1387-1391
43. Brunner-La Rocca H.P., Kaye D.M., Woods R.L., Hastings J., and Esler M.D. Effects of intravenous brain natriuretic peptide on regional sympathetic activity in patients with chronic heart failure as compared with healthy control subjects. J Am Coll Cardiol 37 (2001) 1221-1227
44. Schachinger V., Assmus B., Britten M.B., et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI trial. J Am Coll Cardiol 44 (2004) 1690-1699
45. Assmus B., Schachinger V., Teupe C., et al. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation 106 (2002) 3009-3017